Eagle Global Advisors’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-8,643
| Closed | -$650K | – | 261 |
|
|
2021
Q1 | $650K | Sell |
8,643
-58,998
| -87% | -$4.3M | 0.05% | 169 |
|
|
2020
Q4 | $4.62M | Sell |
67,641
-487
| -0.7% | -$31.7K | 0.36% | 72 |
|
|
2020
Q3 | $3.98M | Sell |
68,128
-504
| -0.7% | -$31.4K | 0.36% | 75 |
|
|
2020
Q2 | $4.46M | Buy |
68,632
+511
| +0.8% | +$32.2K | 0.4% | 67 |
|
|
2020
Q1 | $4.04M | Buy |
68,121
+2,572
| +4% | +$172K | 0.41% | 62 |
|
|
2019
Q4 | $4.87M | Buy |
65,549
+1,535
| +2% | +$108K | 0.25% | 74 |
|
|
2019
Q3 | $4.04M | Buy |
64,014
+9,136
| +17% | +$541K | 0.17% | 84 |
|
|
2019
Q2 | $2.99M | Sell |
54,878
-101,106
| -65% | -$5.44M | 0.12% | 95 |
|
|
2019
Q1 | $8.41M | Buy |
155,984
+10,286
| +7% | +$635K | 0.33% | 59 |
|
|
2018
Q4 | $9.55M | Buy |
145,698
+46,341
| +47% | +$3.46M | 0.41% | 59 |
|
|
2018
Q3 | $7.82M | Sell |
99,357
-3,594
| -3% | -$257K | 0.24% | 73 |
|
|
2018
Q2 | $6.63M | Buy |
102,951
+41,235
| +67% | +$2.72M | 0.21% | 78 |
|
|
2018
Q1 | $3.84M | Sell |
61,716
-869
| -1% | -$62.4K | 0.13% | 115 |
|
|
2017
Q4 | $4.54M | Sell |
62,585
-60,494
| -49% | -$4.4M | 0.14% | 109 |
|
|
2017
Q3 | $10M | Sell |
123,079
-2,122
| -2% | -$168K | 0.3% | 61 |
|
|
2017
Q2 | $10.1M | Sell |
125,201
-2,415
| -2% | -$191K | 0.29% | 65 |
|
|
2017
Q1 | $10M | Buy |
127,616
+1,813
| +1% | +$145K | 0.27% | 62 |
|
|
2016
Q4 | $9.93M | Buy |
125,803
+42,031
| +50% | +$3.4M | 0.27% | 64 |
|
|
2016
Q3 | $7.46M | Sell |
83,772
-2,124
| -2% | -$200K | 0.21% | 81 |
|
|
2016
Q2 | $8.22M | Sell |
85,896
-174
| -0.2% | -$17.3K | 0.24% | 81 |
|
|
2016
Q1 | $8.93M | Sell |
86,070
-429
| -0.5% | -$41.7K | 0.32% | 71 |
|
|
2015
Q4 | $8.46M | Sell |
86,499
-199
| -0.2% | -$19.5K | 0.29% | 75 |
|
|
2015
Q3 | $8.37M | Sell |
86,698
-70
| -0.1% | -$7.36K | 0.28% | 79 |
|
|
2015
Q2 | $9.1M | Buy |
86,768
+5,741
| +7% | +$587K | 0.24% | 77 |
|
|
2015
Q1 | $8.36M | Buy |
81,027
+1,097
| +1% | +$111K | 0.22% | 79 |
|
|
2014
Q4 | $7.7M | Buy |
79,930
+20,855
| +35% | +$1.84M | 0.2% | 85 |
|
|
2014
Q3 | $4.7M | Sell |
59,075
-291
| -0.5% | -$22.9K | 0.11% | 116 |
|
|
2014
Q2 | $4.47M | Sell |
59,366
-1,120
| -2% | -$84.6K | 0.11% | 116 |
|
|
2014
Q1 | $4.53M | Sell |
60,486
-769
| -1% | -$54.3K | 0.14% | 112 |
|
|
2013
Q4 | $4.38M | Buy |
61,255
+2,661
| +5% | +$171K | 0.14% | 116 |
|
|
2013
Q3 | $3.33M | Sell |
58,594
-429
| -0.7% | -$25.6K | 0.12% | 134 |
|
|
2013
Q2 | $3.38M | Buy |
+59,023
| New | +$3.42M | 0.13% | 125 |
|
Other funds holding CVS
Eagle Global Advisors's CVS Position: Q2 2021 in Review
Eagle Global Advisors sold out of CVS Health (CVS) in Q2 2021, closing a stake of 8,643 shares — an estimated $650K sold.
Eagle Global Advisors first reported a position in CVS in Q2 2013 and held it in 32 quarters. The position peaked at $10.1M in Q2 2017. 2,064 funds tracked by Wall St. Rank hold CVS as of Q2 2021.
- Eagle Global Advisors reported no remaining CVS Health position as of Q2 2021 after selling out during the quarter.
- Eagle Global Advisors sold 8,643 CVS Health shares in Q2 2021, an estimated $650K.
- Eagle Global Advisors first reported a position in CVS Health in Q2 2013 and held it in 32 quarters.
- Eagle Global Advisors's CVS Health position peaked at $10.1M in Q2 2017.
- 2,064 funds tracked by Wall St. Rank held CVS Health as of Q2 2021.
Based on Eagle Global Advisors's 13F filing for Q2 2021, filed 15 Jul 2021.